Seroconversion after influenza vaccination in patients with lung cancer

British Journal of Cancer

Volumn 80, Issue 1-2, 1999, Pages 219-220

  Anderson, H ^a   Petrie, K ^b   Berrisford, C ^a   Charlett, A ^c   Thatcher, N ^a   Zambon, M ^d  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

Antibody response; Influenza vaccine; Lung cancer

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032948571     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690342     Document Type: Article

References (7)

1. Department of Health (1996) Immunisation against Infectious Disease, Salisbury DM, Begg NT, (eds) pp 113-120. HMSO: London
2. Editorial (1997) Uptake of vaccine in high risk patients. Commun Dis Rep Weekly 7: 407
3. Lorio AM, Rivosecchi P, Zei P, Neri M and Merlett L (1989) Immune response to trivalent inactivated influenza vaccine in young and elderly subjects. Vaccine 7: 303-306
4. Ortbals DW, Liebhaber H, Presant CA, van Amburg AL and Lee JY (1977) Influenza immunisation of adult patients with malignant diseases. Ann Intern Med 87: 552-557
5. Shildt RA, Luedke DW, Kasai G, El-Beheri S and Laham MN (1979) Antibody response to influenza immunisation in adult patients with malignant disease. Cancer 44: 1629-1635
6. Watkins J (1997) Effectiveness of influenza vaccination policy at targeting patients at high risk of complications during winter 1994-95: Cross Sectional Survey. BMJ 315: 1069-1070
7. Yousuf HM, Englund J, Couch R, Rolston K, Luna M and Goodrich J (1997) Influenza among hospitalised adults with leukaemia. Clinical Infectious Diseases 24: 1095-1099